Xeris Biopharma (XERS) P/E (2020 - 2026)
Xeris Biopharma (XERS) P/E from Dec 31, 2020 to Jun 3, 2026. The TTM Xeris Biopharma (XERS) P/E is 82.54. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Xeris Biopharma (XERS)
| Year | P/E | Change |
|---|---|---|
| 2026 | 82.54 | -100.70% |
| 2025 | -11.86K | +128824.77% |
| 2024 | -9.20 | +75.92% |
| 2023 | -5.23 | +297.04% |
| 2022 | -1.32 | -32.01% |
| 2021 | -1.94 | -85.57% |
| 2020 | -13.42 | N/A |
Comparison Xeris Biopharma (XERS) P/E with competitors
Xeris Biopharma (XERS) P/E is 82.54.